Content deleted Content added
spelling |
Capitalised brand names, as is common (after seeing a bottle of Moderil on eBay). Also italicised them (makes them look a little bit better than simply bold). |
||
(12 intermediate revisions by 9 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = 464380960 |
| verifiedrevid = 464380960 |
||
| IUPAC_name = methyl (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-<nowiki/>{[(2''E'')-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}yohimban-16-carboxylate |
| IUPAC_name = methyl (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-<nowiki/>{[(2''E'')-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}yohimban-16-carboxylate |
||
| image = Rescinnamine.svg |
| image = Rescinnamine.svg |
||
| image2 = [[File:Rescinnamine.png|frameless|rescinnamine 3D BS]] |
|||
| width = 300 |
| width = 300 |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
Line 8: | Line 10: | ||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_status = Rx-only |
| legal_status = Rx-only |
||
| routes_of_administration = |
| routes_of_administration = [[Oral administration|By mouth]] |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
Line 36: | Line 38: | ||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=35 | H=42 | N=2 | O=9 |
| C=35 | H=42 | N=2 | O=9 |
||
| molecular_weight = 634.716 g/mol |
|||
| smiles = [H][C@]26C[C@@H](OC(=O)/C=C/c1cc(OC)c(OC)c(OC)c1)[C@H](OC)[C@@H](C(=O)OC)[C@@]2([H])C[C@]5([H])c4[nH]c3cc(OC)ccc3c4CCN5C6 |
| smiles = [H][C@]26C[C@@H](OC(=O)/C=C/c1cc(OC)c(OC)c(OC)c1)[C@H](OC)[C@@H](C(=O)OC)[C@@]2([H])C[C@]5([H])c4[nH]c3cc(OC)ccc3c4CCN5C6 |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
Line 45: | Line 46: | ||
}} |
}} |
||
'''Rescinnamine''', known by the brand names ''' |
'''Rescinnamine''', known by the brand names '''''Moderil''''', '''''Cinnasil''''', and '''''Anaprel''''', is an [[ACE inhibitor|angiotensin-converting enzyme inhibitor]] used as an [[antihypertensive]] [[medication|drug]]. |
||
It is a [[vinca alkaloid]] obtained from ''[[Rauvolfia serpentina]]''<ref name="pmid13699407">{{cite journal |vauthors=FIFE R, MACLAURIN JC, WRIGHT JH |title=Rescinnamine in treatment of hypertension in hospital clinic and in general practice |journal=British Medical Journal |volume=2 |issue=5216 |pages=1848–50 |date=December 1960 |pmid=13699407 |pmc=2098607 |doi= 10.1136/bmj.2.5216.1848 |
It is a [[vinca alkaloid]] obtained from ''[[Rauvolfia serpentina]]''<ref name="pmid13699407">{{cite journal |vauthors=FIFE R, MACLAURIN JC, WRIGHT JH |title=Rescinnamine in treatment of hypertension in hospital clinic and in general practice |journal=British Medical Journal |volume=2 |issue=5216 |pages=1848–50 |date=December 1960 |pmid=13699407 |pmc=2098607 |doi= 10.1136/bmj.2.5216.1848}}</ref> and other [[species]] of ''[[Rauvolfia]]''.<ref>{{cite journal |journal = Planta Med. |year = 1982 |volume = 44 |issue = 2 |pages = 91–3 |title = Alkaloids of Vinca major cv. Variegata. |vauthors = Balsevich J, Constabel F, Kurz WG |pmid = 17402086 |doi=10.1055/s-2007-971409}}</ref> |
||
== References == |
== References == |
||
{{reflist}} |
{{reflist}} |
||
{{ACE inhibitors}} |
|||
{{Antihypertensives and diuretics}} |
|||
{{Angiotensin receptor modulators}} |
{{Angiotensin receptor modulators}} |
||
[[Category:Indoloquinolizines]] |
|||
[[Category:Tryptamine alkaloids]] |
|||
[[Category:Isoquinoline alkaloids]] |
|||
[[Category:ACE inhibitors]] |
[[Category:ACE inhibitors]] |
||
[[Category:Antihypertensive agents]] |
[[Category:Antihypertensive agents]] |
||
Line 61: | Line 65: | ||
[[Category:Cinnamate esters]] |
[[Category:Cinnamate esters]] |
||
[[Category:Indole ethers at the benzene ring]] |
[[Category:Indole ethers at the benzene ring]] |
||
[[Category:Heterocyclic compounds with 5 rings]] |
|||
[[Category:Methoxy compounds]] |
|||
[[Category:Methyl esters]] |
|||
{{Antihypertensive-stub}} |
{{Antihypertensive-stub}} |
Revision as of 21:18, 30 July 2023
Clinical data | |
---|---|
Trade names | Moderil, Cinnasil, Anaprel |
Other names | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.042.232 |
Chemical and physical data | |
Formula | C35H42N2O9 |
Molar mass | 634.726 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Rescinnamine, known by the brand names Moderil, Cinnasil, and Anaprel, is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
It is a vinca alkaloid obtained from Rauvolfia serpentina[1] and other species of Rauvolfia.[2]
References
- ^ FIFE R, MACLAURIN JC, WRIGHT JH (December 1960). "Rescinnamine in treatment of hypertension in hospital clinic and in general practice". British Medical Journal. 2 (5216): 1848–50. doi:10.1136/bmj.2.5216.1848. PMC 2098607. PMID 13699407.
- ^ Balsevich J, Constabel F, Kurz WG (1982). "Alkaloids of Vinca major cv. Variegata". Planta Med. 44 (2): 91–3. doi:10.1055/s-2007-971409. PMID 17402086.